Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Courageous Conversations ep.3: Facial Recognition Technology and Its Impact on Healthcare

Impetus Digital

- PMLiVE

Bedrock Group celebrates a trio of new hires

Bedrock Group is gearing up for a year of incredible growth with the hire of two new Strategic Solutions Directors as well as an additional Account Manager.

Bedrock Healthcare Communications

- PMLiVE

Researchers discover new antibiotic using AI

First antibiotic to be discovered using this method

- PMLiVE

Tocagen merges with Forte Biosciences after brain cancer fail

New company will focus on Forte's lead skin disease drug

- PMLiVE

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Deal focuses on T cell receptor therapies

- PMLiVE

Immutep spikes on trial of its LAG-3 drug with Keytruda

Impressive mid-stage results in NSCLC and HNSCC

- PMLiVE

Ex-BMS exec jumps to Gilead to lead research group

Gilead appoints Michael Quigley to lead research team

Digital divergence

Combining digital and pharma is proving less easy than previously thought

- PMLiVE

Incyte launches award programme recognising innovation in GVHD community

Programme aims to support people with graft-versus-host disease

- PMLiVE

AbbVie/Allergan merger faces renewed public opposition despite divestments

Consumer groups and public interest organisations raise new concerns

- PMLiVE

Merck KGaA divests allergy business to Dermapharm

The sum of the agreement remains undisclosed

- PMLiVE

Teva’s weak pipeline hit by Tourette’s drug trial failure

Drug wasn't able to improve on placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links